News By Tag
News By Location
Aseptika recognised as leading HealthTech Innovator with listing 2017 Global Digital Health 100
Aseptika Limited (Activ8rlives) has again been recognised as a leading HealthTech Innovator by their listing in the 2017 Global Digital Health 100 List.
By: Aseptika Limited (Activ8rlives)
Digital Health is Maturing
The awards programme run by the Journal of mHealth commented, "reflect the ever-growing importance of mobile, digital and connected solutions in the healthcare industry, the Global Digital Health 100-2017 recognises the significant work being carried out by organisations from around the globe.
While many companies, over the past few years, have failed despite having truly innovative technologies to offer, the 2017 cohort shows that it is essential to not only demonstrate innovation in technology, but also innovation in service and business model development as a requisite to succeeding as a technology company in the healthcare industry".
Identifying the 100
The judging criteria analysed 10 different quantitative and qualitative evaluation metrics including: disruptive impact; proof of concept; technology innovation; social value; effectiveness;
For more information, please visit: www.activ8rlives.com
Activ8rlives, Activ8rlives.com and Active+ are trademarks of Aseptika Ltd.
About Aseptika Limited (Activ8rlives)
Aseptika Ltd began developing Activ8rlives in 2010 and is currently developing its third generation of integrated systems, which can be used by consumers and their healthcare service providers using a wide range of platforms or devices to better enable effective and easy self-monitoring. Incorporating sensors and monitors ranging from consumer accessories to in vitro diagnostics (IVDs). Our focus is: respiratory and cardiovascular disease, cancer, promoting physical activity, and weight management.
Active+ rehabilitation classes integrating Activ8rlives self-monitoring technology began with cardiac rehabilitation classes. These classes have now been extended to include people with cancer in partnership with a local cancer charity HCCN who has pioneered a new exercise programme for patients before during and immediately after their treatment. Active+ is the result of a collaboration between Huntingdonshire District Council (HDC) Active Lifestyles, Huntingdonshire Community Cancer Network (HCCN) and enabled with Aseptika's innovative Activ8rlives health platform and supported by Eastern Academic Health Science Network (Eastern AHSN). This cross-organisational collaboration has been key to its success and deployment – a model Eastern AHSN is hoping to replicate across the Eastern region to reduce the workload of over-stretched NHS Hospitals.
Jessica Auton, Aseptika